The Future of US Pharma and Healthcare: Two Very Different Game-plans
The brawl up to the US election has been almost impossible to miss. Amidst watching Trump and Hillary lock-horns, Pharma-IQ examines one of the most important battlegrounds discussed - the future of US healthcare.The stakes are highThe US pharma market is labelled as the world’s most important national market.1 The United States alone holds some 40% share of the global pharma industry. With many of pharma’s leading entities calling the US home, this region has always been recognised as a m...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.